A Study of ASP2138 Given by Itself or Given With Other Cancer Treatments in Adults With Stomach Cancer, Gastroesophageal Junction Cancer, or Pancreatic Cancer | MicrobiomeTrials
A Study of ASP2138 Given by Itself or Given With Other Cancer Treatments in Adults With Stomach Cancer, Gastroesophageal Junction Cancer, or Pancreatic Cancer
RecruitingPHASE1INTERVENTIONAL
Trial Details
Start: 2022-06-07Est. Completion: 2028-05-31
Enrollment target: 398 participants
Locations
University of California Irvine Medical Center, Orange, California, United States
UCLA Dept of Medicine - Hematology/Oncology, Santa Monica, Santa Monica, California, United States
Northwestern University, Chicago, Illinois, United States
University of Kansas Cancer Center, Westwood, Kansas, United States
Rutgers Cancer Institute of New Jersey, New Brunswick, New Jersey, United States
NYU Langone Medical Center - NYU Medical Oncology Associates, New York, New York, United States
Columbia University, New York, New York, United States
Memorial Sloan Kettering Cancer Center, New York, New York, United States
Duke Children's Hospital and Health Center, Durham, North Carolina, United States
Wake Forest University Baptist Health, Winston-Salem, North Carolina, United States
UT Southwestern Medical Center, Dallas, Texas, United States
Virginia Mason Medical Center, Seattle, Washington, United States
Froedtert Hospital and the Medical College of Wisconsin, Milwaukee, Wisconsin, United States
Sun Yat-sen University Cancer Center, Guangzhou, Guangdong, China
Henan Cancer Hospital, Zhengzhou, Henan, China
Union Hospital affiliated to Tongji Medical College of Huazhong University of Science and Technology, Wuhan, Hubei, China
Ruijin Hospital Affiliated to Shanghai Jiao Tong University School of Medicine, Shanghai, Shanghai Municipality, China
The First Affiliated Hospital, College of Medicine, Zhejiang University, Hangzhou, Zhejiang, China
Site FR33005, Vaillant, Villejuif, France
Site FR33003, Lyon, France
Site FR33004, Marseille, France
Site FR33006, Poitiers, France
Site FR33001, Saint-Herblain, France
Site FR33002, Toulouse, France
Site IT39004, Milan, Italy
Site IT39001, Milan, Italy
Site IT39005, Rozzano, Italy
Site IT39003, Verona, Italy
Aichi Cancer Center, Nagoya, Aichi-ken, Japan
National Cancer Center Hospital East, Kashiwa, Chiba, Japan
Kanagawa Cancer Center, Yokohama, Kanagawa, Japan
Kindai University Hospital, Sakai, Osaka, Japan
The University of Osaka Hospital, Suita, Osaka, Japan
National Cancer Center Hospital, Chuo-ku, Tokyo, Japan
The Cancer Institute Hospital of Japanese Foundation for Cancer Research, Koto-ku, Tokyo, Japan
PanOncology Trials, San Juan, Puerto Rico
Site KR82004, Seongnam-si, Gyeonggi-do, South Korea